MENU
Home
Posts of importance
How to help us
RSS feed
CSF proteomics of semorinemab Alzheimer's disease trials identifies cell-type specific signatures.
CSF proteomics of semorinemab Alzheimer's disease trials identifies cell-type specific signatures.
03 November 1956
- Posted by
system
Read the original article on Pubmed
AD
Related Posts
* Qualité du sommeil, espaces périvasculaires et marqueurs...
...
* Quadruple Misfolded Proteins in Older Adults
...
Please, help us continue to provide valuable information:
